Ilona E Kryczek
Associate Research Scientist
Surgery
[email protected]

Available to mentor
Ilona E Kryczek
Associate Research Scientist
  • Recent Publications
    • Recent Publications See All Publications
    • Journal Article
      Durvalumab and guadecitabine in advanced clear cell renal cell carcinoma: results from the phase Ib/II study BTCRC-GU16-043.
      Zakharia Y, Singer EA, Acharyya S, Garje R, Joshi M, Peace D, Baladandayuthapani V, Majumdar A, Li X, Lalancette C, Kryczek I, Zou W, Alva A. Nat Commun, 2024 Feb 1; 15 (1): 972 DOI:10.1038/s41467-024-45216-z
      PMID: 38302476
    • Journal Article
      PAD4 controls tumor immunity via restraining the MHC class II machinery in macrophages.
      Pitter MR, Kryczek I, Zhang H, Nagarsheth N, Xia H, Wu Z, Tian Y, Okla K, Liao P, Wang W, Zhou J, Li G, Lin H, Vatan L, Grove S, Wei S, Li Y, Zou W. Cell Rep, 2024 Mar 26; 43 (3): 113942 DOI:10.1016/j.celrep.2024.113942
      PMID: 38489266
    • Journal Article
      Microbiota-dependent activation of CD4+ T cells induces CTLA-4 blockade-associated colitis via Fcγ receptors.
      Lo BC, Kryczek I, Yu J, Vatan L, Caruso R, Matsumoto M, Sato Y, Shaw MH, Inohara N, Xie Y, Lei YL, Zou W, Núñez G. Science, 2024 Jan 5; 383 (6678): 62 - 70. DOI:10.1126/science.adh8342
      PMID: 38175892
    • Journal Article
      PIKfyve controls dendritic cell function and tumor immunity.
      Choi JE, Qiao Y, Kryczek I, Yu J, Gurkan J, Bao Y, Gondal M, Tien JC-Y, Maj T, Yazdani S, Parolia A, Xia H, Zhou J, Wei S, Grove S, Vatan L, Lin H, Li G, Zheng Y, Zhang Y, Cao X, Su F, Wang R, He T, Cieslik M, Green MD, Zou W, Chinnaiyan AM. bioRxiv, 2024 Jul 1; DOI:10.1101/2024.02.28.582543
      PMID: 38464258
    • Journal Article
      Intersection of immune and oncometabolic pathways drives cancer hyperprogression during immunotherapy.
      Li G, Choi JE, Kryczek I, Sun Y, Liao P, Li S, Wei S, Grove S, Vatan L, Nelson R, Schaefer G, Allen SG, Sankar K, Fecher LA, Mendiratta-Lala M, Frankel TL, Qin A, Waninger JJ, Tezel A, Alva A, Lao CD, Ramnath N, Cieslik M, Harms PW, Green MD, Chinnaiyan AM, Zou W. Cancer Cell, 2023 Feb 13; 41 (2): 304 - 322.e7. DOI:10.1016/j.ccell.2022.12.008
      PMID: 36638784
    • Journal Article
      PIKfyve, expressed by CD11c-positive cells, controls tumor immunity.
      Choi JE, Qiao Y, Kryczek I, Yu J, Gurkan J, Bao Y, Gondal M, Tien JC-Y, Maj T, Yazdani S, Parolia A, Xia H, Zhou J, Wei S, Grove S, Vatan L, Lin H, Li G, Zheng Y, Zhang Y, Cao X, Su F, Wang R, He T, Cieslik M, Green MD, Zou W, Chinnaiyan AM. Nat Commun, 2024 Jun 28; 15 (1): 5487 DOI:10.1038/s41467-024-48931-9
      PMID: 38942798
    • Proceeding / Abstract / Poster
      Abstract 7479: Targeting the lipid kinase PIKfyve upregulates surface expression of MHC class I to augment cancer immunotherapy
      Borker P, Bao Y, Qiao Y, Chinnaiyan A, Choi JE, Zhang Y, Mannan R, Cheng C, He T, Zheng Y, Yu J, Gondal M, Cruz G, Grove SS, Cao X, Su F, Wang R, Chang Y, Kryczek I, Cieslik M, Green MD, Zou W. Cancer Research, 2024 Mar 22; 84 (6_Supplement): 7479 - 7479. DOI:10.1158/1538-7445.am2024-7479
    • Preprint
      PIKfyve controls dendritic cell function and tumor immunity
      Choi JE, Qiao Y, Kryczek I, Yu J, Gurkan J, Bao Y, Gondal M, Tien JC-Y, Maj T, Yazdani S, Parolia A, Xia H, Zhou J, Wei S, Grove S, Vatan L, Lin H, Li G, Zheng Y, Zhang Y, Cao X, Su F, Wang R, He T, Cieslik M, Green MD, Zou W, Chinnaiyan AM. bioRxiv, DOI:10.1101/2024.02.28.582543